Here’s what you should know.
1. Researchers use the biomarkers to test the effectiveness of Cetuximab, a drug which blocks the receptor for the epidermal growth factor, and 5FU, a chemotherapy drug.
2. Berlin, Germany-based Charite University Hospital and University Hospital Graz (Austria) researchers collected tumor samples from more than 100 colorectal cancer patients.
3. The researchers analyzed the tumors defining the RNA molecules in a given tissue to produce the cancer’s biomarkers
4. By establishing biomarkers, scientists can better engineer treatments that’ll combat bowel cancer.
More articles on gastroenterology/endoscopy:
GI leader to know: Dr. David Carron of GI Associates
Allergan’s Q4 beats analysts’ estimates: 4 insights
Dr. Democleia Panagou Gottesman named ‘Leading Physician of the World’ — 4 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
